Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses.

Shunichiro Kuramitsu,Masasuke Ohno,Fumiharu Ohka,Shuichiro Shiina,Akane Yamamichi,Akira Kato,Kuniaki Tanahashi,Kazuya Motomura,Goro Kondo,Michihiro Kurimoto,Takeshi Senga,Toshihiko Wakabayashi,Atsushi Natsume

Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses.

2015

Shunichiro Kuramitsu
Masasuke Ohno
Fumiharu Ohka
Shuichiro Shiina
Akane Yamamichi
Akira Kato
Kuniaki Tanahashi
Kazuya Motomura
Goro Kondo
Michihiro Kurimoto
Takeshi Senga
Toshihiko Wakabayashi
Atsushi Natsume

Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses

Keywords:

Biology
Synapse
Virology
Chimeric antigen receptor
Molecular biology
Lenalidomide
Interleukin Receptor Common gamma Subunit
Immune system
Epidermal growth factor receptor
Immunological Synapses
Interferon gamma
Antibody
CD3
CD28
Cell therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations